Back to School: How biopharma can reboot drug development. Access exclusive analysis here
DNA posted 3Q07 non-GAAP diluted EPS of $0.73, beating by a penny the Street's estimate of $0.72 and up 24% from $0.59 in
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury